Application and management of continuous glucose monitoring in diabetic kidney disease

Table 1 The Pearson correlation between continuous glucose monitoring metrics and glycemic biomarkers on chronic kidney disease (number of participants)

CKD stages	1-2	3a	3b	4	5	Ref.
HbA1c	0.576 (64)	0.266 (56)	0.266 (56)	0.296 (36)	0.296 (36)	Lu et al[17]
			0.68 (33)	0.52 (43)	0.22 (14)	Ling et al[18]
		0.79 (14)	0.79 (14)	0.34 (29)	0.34 (29)	Lo et al[19]
				0.38 (25)	0.38 (25)	Vos et al[20]
		0.78 (80)	0.78 (80)	0.78 (80)	0.78 (80)	Zelnick et al[12]
Glycated albumin				0.54 (25)	0.54 (25)	Vos et al[20]
Fructosamine		0.78 (80)	0.78 (80)	0.78 (80)	0.78 (80)	Zelnick et al[12]
		0.71 (80)	0.71 (80)	0.71 (80)	0.71 (80)	Zelnick et al[12]

CKD: Chronic kidney disease; HbA1c: Hemoglobin A1c.